Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519 - Alma, Harma; de Jong, Corina; Kocks, Janwillem; van der Molen, Thys (Frontiers in Pharmacology, 2020)